Pain Management Research Institute, Faculty of Medicine and Health, the University of Sydney, Sydney, Australia.
School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, NSW, Australia.
Pain. 2022 Feb 1;163(2):e246-e260. doi: 10.1097/j.pain.0000000000002336.
Tapering opioids for chronic pain can be challenging for both patients and prescribers, both of whom may be unsure of what to expect in terms of pain, distress, activity interference, and withdrawal symptoms over the first few weeks and months of the taper. To better prepare clinicians to provide patient-centred tapering support, the current research used prospective longitudinal qualitative methods to capture individual-level variation in patients' experience over the first few months of a voluntary physician-guided taper. The research aimed to identify patterns in individuals' experience of tapering and explore whether patient characteristics, readiness to taper, opioid tapering self-efficacy, or psychosocial context were related to tapering trajectory. Twenty-one patients with chronic noncancer pain commencing tapering of long-term opioid therapy were recruited from a metropolitan tertiary pain clinic (n = 13) and a regional primary care practice (n = 8). Semistructured phone interviews were conducted a mean of 8 times per participant over a mean duration of 12 weeks (N = 173). Four opioid-tapering trajectories were identified, which we characterised as thriving, resilient, surviving, and distressed. High and low readiness to taper was a defining characteristic of thriving and distressed trajectories, respectively. Life adversity was a prominent theme of resilient and distressed trajectories, with supportive relationships buffering the effects of adversity for those who followed a resilient trajectory. Discussion focuses on the implications of these findings for the preparation and support of patients with chronic pain who are commencing opioid tapering.
对于慢性疼痛患者和处方医生来说,逐渐减少阿片类药物的用量可能具有挑战性,因为他们都可能不确定在逐渐减少的最初几周和几个月内,疼痛、痛苦、活动干扰和戒断症状会如何变化。为了让临床医生更好地为患者提供以患者为中心的逐渐减少药物剂量的支持,当前的研究采用前瞻性纵向定性方法,从个体层面捕捉患者在自愿接受医生指导的逐渐减少药物剂量的最初几个月中的体验变化。研究旨在确定个体逐渐减少药物剂量体验中的模式,并探讨患者特征、逐渐减少药物剂量的准备情况、阿片类药物逐渐减少自我效能或心理社会背景是否与逐渐减少药物剂量的轨迹有关。从一家大都市三级疼痛诊所(n = 13)和一家地区基层医疗实践招募了 21 名开始逐渐减少长期阿片类药物治疗的慢性非癌性疼痛患者(n = 8)。对参与者进行了平均 8 次的半结构化电话访谈,平均持续时间为 12 周(n = 173)。确定了 4 种阿片类药物逐渐减少药物剂量的轨迹,我们将其描述为茁壮成长、有弹性、生存和痛苦。高和低的逐渐减少药物剂量的准备情况分别是茁壮成长和痛苦轨迹的决定性特征。生活逆境是有弹性和痛苦轨迹的一个突出主题,对于那些遵循有弹性轨迹的人来说,支持性的关系缓冲了逆境的影响。讨论重点关注这些发现对开始阿片类药物逐渐减少药物剂量的慢性疼痛患者的准备和支持的影响。